DXR insider transactions

SEC Form 4 filed by Feldschuh Michael Richard

SEC Form 4 filed by Michel Robert J

SEC Form 4 filed by Jefferies John

Chief Financial Officer Michel Robert J bought 3,000 units of Daxor Common Stock, increasing direct ownership by 18% to 20,050 units (SEC Form 4)

Chief Scientific Officer Feldschuh Jonathan Adam bought 18,000 units of Daxor Common Stock, increasing direct ownership by 50% to 53,908 units (SEC Form 4)

Chief Medical Officer Jefferies John bought 2,344 units of Daxor Common Stock, increasing direct ownership by 15% to 17,616 units (SEC Form 4)

New insider Jefferies John claimed ownership of 15,272 units of Daxor Common Stock (SEC Form 3)

SEC Form 4 filed by Director Desrosiers Caleb

SEC Form 4 filed by Director Goudie Joy S.

SEC Form 4 filed by Director Feuer Edward

SEC Form 4 filed by Director Cremisi Henry D.

Chief Executive Officer Feldschuh Michael Richard bought $16,277 worth of Daxor Common Stock (2,063 units at $7.89), increasing direct ownership by 0.98% to 212,694 units (SEC Form 4)

Chief Executive Office Feldschuh Michael Richard bought $8,130 worth of Daxor Common Stock (1,000 units at $8.13), increasing direct ownership by 0.48% to 210,631 units (SEC Form 4)

Amendment: Chief Executive Officer Feldschuh Michael Richard bought $11,518 worth of Daxor Common Stock (1,492 units at $7.72), increasing direct ownership by 0.72% to 208,984 units (SEC Form 4)

Chief Executive Officer Feldschuh Michael Richard bought $5,273 worth of Daxor Common Stock (647 units at $8.15), increasing direct ownership by 0.31% to 209,631 units (SEC Form 4)

Chief Executive Officer Feldschuh Michael Richard bought $25,805 worth of Daxor Common Stock (3,360 units at $7.68), increasing direct ownership by 2% to 210,852 units (SEC Form 4)

Chief Financial Officer Michel Robert J bought $8,000 worth of Daxor Common Stock (1,000 units at $8.00), increasing direct ownership by 6% to 17,050 units (SEC Form 4)

Chief Scientific Officer Feldschuh Jonathan Adam bought 32,000 units of Daxor Common Stock, increasing direct ownership by 819% to 35,908 units (SEC Form 4)

Chief Executive Officer Feldschuh Michael Richard bought 45,000 units of Daxor Common Stock, increasing direct ownership by 28% to 207,492 units (SEC Form 4)

Chief Financial Officer Michel Robert J bought 4,750 units of Daxor Common Stock, increasing direct ownership by 46% to 15,050 units (SEC Form 4)

SEC Form 4 filed by Director Desrosiers Caleb

SEC Form 4 filed by Director Goudie Joy S.

SEC Form 4 filed by Director Feuer Edward

SEC Form 4 filed by Director Cremisi Henry D.

Michel Robert J bought $6,525 worth of Daxor Common Stock (750 units at $8.70), increasing direct ownership by 7% to 11,300 units (SEC Form 4)

Feuer Edward bought $7,210 worth of Daxor Common Stock (1,000 units at $7.21) (SEC Form 4)

Michel Robert J bought $930 worth of Daxor Common Stock (120 units at $7.75), increasing direct ownership by 1% to 10,550 units (SEC Form 4)

Michel Robert J bought $1,395 worth of Daxor Common Stock (180 units at $7.75), increasing direct ownership by 2% to 10,430 units (SEC Form 4)

Feldschuh Michael Richard bought $6,240 worth of Daxor Common Stock (800 units at $7.80), increasing direct ownership by 0.49% to 162,492 units (SEC Form 4)

Michel Robert J bought $3,970 worth of Daxor Common Stock (500 units at $7.94), increasing direct ownership by 5% to 10,250 units (SEC Form 4)

Feldschuh Michael Richard was granted 84 units of Daxor Common Stock, increasing direct ownership by 0.05% to 160,692 units (SEC Form 4)

Feldschuh Michael Richard bought $10,986 worth of Daxor Common Stock (1,402 units at $7.84), increasing direct ownership by 0.88% to 161,608 units (SEC Form 4)

Michel Robert J was granted 2,000 units of Daxor Common Stock, increasing direct ownership by 26% to 9,750 units (SEC Form 4)

Michel Robert J bought $4,510 worth of Daxor Common Stock (500 units at $9.02), increasing direct ownership by 7% to 7,750 units (SEC Form 4)

SEC Form 4: Estate Of Joseph Feldschuh gifted 25,000 shares, decreasing direct ownership by 0.97% to 2,549,455 units

SEC Form 4 filed by Michel Robert J

SEC Form 4 filed by Cremisi Henry D.

SEC Form 4 filed by Feldschuh Michael Richard

SEC Form 4 filed by Desrosiers Caleb

SEC Form 4 filed by Goudie Joy S.

SEC Form 4 filed by Feuer Edward

SEC Form 4 filed by Feldschuh Jonathan Adam

SEC Form 4 filed by Lombard James A

SEC Form 4 filed by Feldschuh Michael Richard

SEC Form 4 filed by Goudie Joy S.

SEC Form 4: Desrosiers Caleb bought $29,992 worth of Daxor Common Stock (3,157 units at $9.50)

SEC Form 4: Michel Robert J bought $10,000 worth of Daxor Common Stock (1,000 units at $10.00), increasing direct ownership by 16% to 7,250 units

SEC Form 4 filed by Lombard James A

SEC Form 4 filed by Cremisi Henry D.

SEC Form 4 filed by Goudie Joy S.

SEC Form 4 filed by Feuer Edward

SEC Form 4 filed by Desrosiers Caleb

SEC Form 3 filed by new insider Desrosiers Caleb

SEC Form 4 filed by Feuer Edward

SEC Form 4 filed by Goudie Joy S.

SEC Form 4 filed by LOMBARD JAMES A

SEC Form 4 filed by Cremisi Henry D.

SEC Form 4: Michel Robert J was granted 2,000 units of Daxor Common Stock, increasing direct ownership by 47% to 6,250 units

SEC Form 4: Michel Robert J bought $10,250 worth of Daxor Common Stock (1,000 units at $10.25), increasing direct ownership by 31% to 4,250 units

SEC Form 4: Feldschuh Michael Richard bought $43,386 worth of Common Stock (4,200 units at $10.33), increasing direct ownership by 3% to 158,206 units